We affirm DexCom at Neutral following its first quarter 2013 results.
Medical Products Companies, Particularly Those Aimed at Surgical Procedures, Generating Substantial Free Cash and Showing High Returns on CapitalMay 17
DexCom's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)Seeking Alpha May 16
DexCom's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)
DexCom, Inc. today announced that management will present an update on DexCom at the following upcoming investor conferences:
Dexcom's loss shrinks year over year in the first quarter 2013 on higher revenues.
DexCom's CEO Discusses Q1 2013 Results - Earnings Call Transcript
DexCom, Inc. today reported its unaudited financial results as of and for the quarter ended March 31, 2013.